Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ingiridur Skirnisdottir"'
Autor:
Kathrine Bjersand, Tomas Seidal, Inger Sundström-Poromaa, Helena Åkerud, Ingiridur Skirnisdottir
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179363 (2017)
OBJECTIVES:To evaluate the prognostic effect of the Heterogeneous nuclear ribonucleoprotein type M (HNRPM) and Solute carrier 1A5 (SLC1A5) in FIGO-stages I-II epithelial ovarian cancer. METHODS:A retrospective cohort study was designed to investigate
Externí odkaz:
https://doaj.org/article/818ba5719ccc419e8e376d44675e3f65
Publikováno v:
Annals of Clinical Oncology. :1-8
Background: The incidence of cervical cancer in Sweden decreased to 8/100,000 in the year 2011 but has from 2014 increased to 11/100,000. The noted increase was, mainly observed in FIGO-stages IA-IB, where patients usually are asymptomatic and detect
Publikováno v:
Cancer genomicsproteomics. 16(6)
Background/Aim: The aim of the present study was to evaluate the association between body mass index (BMI), the biomarker p27, and the clinical factors in FIGO-stages I-II ovarian cancer. Patients and Methods: A total of 128 patients with ovarian can
Publikováno v:
International Journal of Gynecological Cancer
Epithelial ovarian cancer (EOC) is still the leading cause of death among women with gynaecological malignancies.1 Based on histopathology and molecular genetic alterations, ovarian carcinomas are divided into 5 main histological types.2 Furthermore,
Publikováno v:
International journal of oncology. 53(4)
The aim of the present retrospective cohort study was to investigate the prognostic effect of epidermal growth factor receptor (EGFR) and the angiogenesis regulator vascular endothelial growth factor receptor 2 (VEGF‑R2) on disease-free survival (D
Publikováno v:
International Journal of Oncology
The aim of this study was to evaluate prognostic effect of the angiogenesis regulators VEGF-R1, VEGF-R2 and VEGF-A for recurrent disease and disease-free survival (DFS), and their relation to the apoptosis regulator p53, in 131 patients with FIGO-sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::671b3f1518ac0863f19d3dfce6edc44b
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-279549
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-279549
Autor:
Ingiridur Skirnisdottir, Tomas Seidal
Publikováno v:
International Journal of Gynecological Cancer. 21:1024-1031
The objective of the study was to evaluate the prognostic effect of p53, PTEN, and concomitant p53 PTEN status on clinicopathologic features, recurrent disease, and disease-free survival (DFS) of 131 patients in FIGO stages I to II with epithelial ov
Publikováno v:
International Journal of Cancer. 123:1897-1901
The aim of the study was to investigate long-term trends in the incidence of borderline tumors and ovarian cancer in Sweden during 1960-2005, based on data from the population-based Swedish Cancer Register. We identified 6,288 patients with borderlin
Publikováno v:
Gynecologic Oncology. 105:166-171
Objective The aim of this register study was to determine occurrence of non-genital ovarian metastasis detected by gynecologic surgery presented as ovarian neoplasm in Sweden from 1 January 1990 to 31 December 2003. Origin of metastases and time of d
Publikováno v:
International Journal of Gynecologic Cancer. 12:265-276
Skirnisdóttir I, Seidal T, Gerdin E, Sorbe B. The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy.Epithelial ovarian cancer is one of the major causes of death among women.